Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 3:18 pm Unchanged |
2023-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY |
ARMISTICE CAPITAL LLC | 97,600 2.730% |
0 (Unchanged) |
Filing History |
| 2024-02-02 8:32 pm Purchase |
2023-09-29 | 13G | Unicycive Therapeutics, Inc. UNCY |
NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 212,175 6.100% |
212,175 (New Position) |
Filing History |
| 2024-01-22 4:27 pm Purchase |
2023-06-26 | 13G | Aeglea BioTherapeutics, Inc. AGLE |
Logos Global Management LP | 3,469,927 9.900% |
3,469,927 (New Position) |
Filing History |
| 2023-07-14 4:30 pm Purchase |
2023-07-11 | 13G | Unicycive Therapeutics, Inc. UNCY |
Vivo Opportunity Fund Holdings, L.P. | 5,996,173 9.990% |
5,996,173 (New Position) |
Filing History |
| 2023-07-06 5:23 pm Purchase |
2023-06-26 | 13G | Unicycive Therapeutics, Inc. UNCY |
BIOTECHNOLOGY VALUE FUND L P | 347,023 9.990% |
347,023 (New Position) |
Filing History |
| 2023-07-06 4:30 pm Purchase |
2023-06-26 | 13G | Unicycive Therapeutics, Inc. UNCY |
RA Capital Management, L.P. | 347,069 9.990% |
347,069 (New Position) |
Filing History |
| 2023-02-14 4:52 pm Sale |
2022-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY |
Nantahala Capital Management LLC | 120,742 8.000% |
-3,934 (-3.16%) |
Filing History |
| 2023-02-14 1:41 pm Purchase |
2022-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY |
ARMISTICE CAPITAL LLC | 97,600 6.080% |
17,600 (+22.00%) |
Filing History |
| 2022-02-14 9:37 pm Purchase |
2021-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY |
ARMISTICE CAPITAL LLC | 80,000 5.100% |
80,000 (New Position) |
Filing History |
| 2022-02-14 08:35 am Purchase |
2021-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY |
Nantahala Capital Management LLC | 124,676 8.000% |
124,676 (New Position) |
Filing History |
| 2022-02-14 06:11 am Purchase |
2021-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY |
Altium Capital Management LLC | 17,600 1.200% |
17,600 (New Position) |
Filing History |
| 2022-01-20 4:23 pm Purchase |
2021-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY |
Rosalind Advisors Inc. | 96,948 6.500% |
15,693 (+19.31%) |
Filing History |
| 2021-09-23 4:54 pm Purchase |
2021-09-14 | 13G | Unicycive Therapeutics, Inc. UNCY |
Rosalind Advisors Inc. | 81,256 5.600% |
81,256 (New Position) |
Filing History |